Ultra-Processed Foods: Scientist’s Daily Diet – The Washington Post
- On February 29, 2024, the Supreme Court overturned a settlement that shielded members of the Sackler family, owners of Purdue Pharma, from civil lawsuits related to the opioid...
- The case centered around Purdue Pharma's bankruptcy proceedings and a deal reached with several states and other creditors.
- The central question before the Court was whether bankruptcy law allows a court to discharge claims against individuals who haven't themselves filed for bankruptcy, but who are alleged...
“`html
The Supreme CourtS Ruling on Purdue Pharma and the Sackler Family
What Happened?
On February 29, 2024, the Supreme Court overturned a settlement that shielded members of the Sackler family, owners of Purdue Pharma, from civil lawsuits related to the opioid crisis. The ruling allows lawsuits against the Sacklers to proceed,potentially exposing them to billions of dollars in damages.
The case centered around Purdue Pharma’s bankruptcy proceedings and a deal reached with several states and other creditors. This deal granted the Sacklers immunity from future lawsuits in exchange for contributing up to $6 billion to abate the opioid crisis. The Justice Department argued that this immunity violated federal bankruptcy law, specifically the provision allowing lawsuits against individuals who have committed fraud.
The Core Legal Issue
The central question before the Court was whether bankruptcy law allows a court to discharge claims against individuals who haven’t themselves filed for bankruptcy, but who are alleged to have participated in fraudulent conduct that contributed to a company’s bankruptcy. The Justice Department contended that the bankruptcy code does not permit such broad immunity. The court agreed, finding that the bankruptcy code’s protections are limited to those who are actually debtors in bankruptcy.
Justice Neil Gorsuch, writing for the majority, emphasized that the bankruptcy code’s language is clear. He stated that the settlement improperly attempted to shield non-debtors from liability,a practice not authorized by the law. The decision effectively reinstates the ability for victims of the opioid crisis to seek redress directly from the Sackler family.
Who is Affected?
This ruling has far-reaching consequences for several groups:
- The Sackler Family: Thay now face the prospect of notable financial liability and potential personal legal battles.
- States and Localities: States and municipalities that have sued the Sacklers for damages related to the opioid crisis can now pursue those claims. Many have already filed lawsuits, and this ruling allows them to move forward.
- Victims of the Opioid Crisis: Individuals and families impacted by opioid addiction and overdose deaths may have a pathway to seek compensation for their losses.
- Purdue Pharma Creditors: The future of Purdue Pharma’s bankruptcy plan is now uncertain, potentially impacting the distribution of funds to creditors.
The opioid crisis has caused immense suffering across the United States.According to the Centers for Disease Control and Prevention (CDC), over 107,000 people died from drug overdoses in 2022, with opioids being involved in nearly 70% of those deaths.
Timeline of Key Events
| Date | Event |
|---|---|
| 1996 | OxyContin, Purdue Pharma’s highly addictive opioid painkiller, is released. |
| Early 2000s | The opioid crisis begins to escalate as OxyContin use and addiction rates rise. |
| 2019 | Purdue Pharma files for bankruptcy amid thousands of lawsuits. |
| 2022 | A settlement is reached granting the Sackler family immunity from future lawsuits. |
| February 29, 2024 | the Supreme Court overturns the settlement, allowing lawsuits against the Sacklers to proceed. |
What does This Mean for Purdue Pharma’s Bankruptcy?
The Supreme Court’s decision throws Purdue Pharma’s bankruptcy plan into disarray. The original plan hinged on the Sackler family’s contribution of up to $6 billion and their